Overall rank by patents
#2,172
of 49,997 tracked assignees
USPTO PatentsView assignee record - 181 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Devicor ranks #2,172 of 49,997 tracked US assignees by granted-patent volume, with 181 patents across 21 technology areas.
USPTO PatentsView assignee plate
Corpus R2172 · US Corporation #2,172 · 181 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Enphase Energy, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cygames · near
47 score
Devicor Medical… · this assignee
47 score
dSPACE digital… · near
47 score
Impossible Foods · near
47 score
OnPoint Medical · near
47 score
3D Lighting… · lowest
7 score
What this shows Devicor's Innovation Score is 46.8/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Devicor Medical Products, Inc. is a focused PatentsView assignee: 21 CPC subclasses with 91.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (31 grants) versus a trough of 7 in 2023. By volume, Devicor sits between Pall Corporation and The Sherwin-Williams Company.
From 2019–2021 to 2022–2024, Devicor Medical Products, Inc. moved from 56 to 28 grants (0.50x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,703. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Pall Corporation
182 patents
TPK Touch Solutions (XIAMEN) Inc.
182 patents
Toshiba Global Commerce Solutions, Inc.
182 patents
Zhejiang Geely Holding Group Co., Ltd.
182 patents
Enphase Energy, Inc.
181 patents
Mentor Acquisition One, LLC
181 patents
Piaggio & C. SPA
181 patents
The Sherwin-Williams Company
181 patents
Devicor Medical Products, Inc.
181 patents
What this shows Devicor holds 181 patents at rank #2,172, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,172 in granted patent volume.
Other assignees with the most granted patents in Devicor's primary technology class.
Two PlainPatent-derived peer sets for Devicor, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (47 here).
Nearest assignees by average claims per patent (15.6 here).
Devicor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 18 | 9.9% |
| 2016 | 31 | 17.1% |
| 2017 | 23 | 12.7% |
| 2018 | 19 | 10.5% |
| 2019 | 21 | 11.6% |
| 2020 | 12 | 6.6% |
| 2021 | 23 | 12.7% |
| 2022 | 11 | 6.1% |
| 2023 | 7 | 3.9% |
| 2024 | 10 | 5.5% |
| 2025partial year | 6 | 3.3% |
Top 15 of 21 technology areas
Overall rank by patents
#2,172
of 49,997 tracked assignees
46.8 out of 100
What to do with this data
Devicor Medical Products, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.